BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Julphar
Johnson and Johnson
Moodys
Federal Trade Commission
Harvard Business School
Farmers Insurance
Queensland Health
Colorcon
Boehringer Ingelheim
Cerilliant

Generated: January 22, 2018

DrugPatentWatch Database Preview

TRANDATE Drug Profile

« Back to Dashboard

US Patents and Regulatory Information for TRANDATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sebela Ireland Ltd TRANDATE labetalol hydrochloride INJECTABLE;INJECTION 019425-001 Dec 31, 1985 DISCN Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Glaxosmithkline TRANDATE HCT hydrochlorothiazide; labetalol hydrochloride TABLET;ORAL 019174-002 Apr 10, 1987 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Cnty Line Pharms TRANDATE labetalol hydrochloride TABLET;ORAL 018716-003 Aug 1, 1984 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Glaxosmithkline TRANDATE HCT hydrochlorothiazide; labetalol hydrochloride TABLET;ORAL 019174-003 Apr 10, 1987 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Cnty Line Pharms TRANDATE labetalol hydrochloride TABLET;ORAL 018716-001 May 24, 1985 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Cnty Line Pharms TRANDATE labetalol hydrochloride TABLET;ORAL 018716-002 Aug 1, 1984 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Glaxosmithkline TRANDATE HCT hydrochlorothiazide; labetalol hydrochloride TABLET;ORAL 019174-001 Apr 10, 1987 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Cnty Line Pharms TRANDATE labetalol hydrochloride TABLET;ORAL 018716-004 Aug 1, 1984 DISCN Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Glaxosmithkline TRANDATE HCT hydrochlorothiazide; labetalol hydrochloride TABLET;ORAL 019174-004 Apr 10, 1987 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for TRANDATE

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Citi
AstraZeneca
Dow
UBS
Moodys
Fish and Richardson
Chinese Patent Office
Mallinckrodt
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot